Canada markets closed

InnoCan Pharma Corporation (IP4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.21400.0000 (0.00%)
At close: 07:19PM CEST

InnoCan Pharma Corporation

1015, 926 – 5 Avenue SW
Calgary, AB T2P 0N7
Canada
403-777-1519
https://innocanpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Ron MayronExecutive Chairman125.78kN/A1963
Ms. Iris BincovichCEO & Director311.68kN/A1970
Mr. Nelson Harvey Halpern F.C.A., FCPAChief Financial Officer59.19kN/A1959
Mr. Roni KamhiCOO & CEO of BI Sky Global212.72kN/A1973
Mr. Eyal Flom L.L.M., M.B.A.Director & Company SecretaryN/AN/A1967
Mr. Yoram DruckerFounder & Executive VP of Business Development160kN/A1965
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments, Pharmaceuticals and Consumer Wellness. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management. The company is also involved in the development and sale of CBD-integrated pharmaceuticals and topical products. In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company offers its products under the Innocan Pharma, R&G Relief & Go, Shir, Synony, and Add On trade names. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.

Corporate Governance

InnoCan Pharma Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.